The quality of health monitoring relies heavily upon the quality of the testing and the correctness of the results. Specialized Reference Baneux PJR, LeNet JL (1997). An interlaboratory comparison of serologic test results for Encephalitozoon cuniculi infection in rabbits points to the need for accreditation of laboratory animal diagnostic laboratories.
Introduction

Health monitoring
The use of microbiologically defined animals in biomedical research has become standard practice in the last few decades. Microbiological standardization has reduced the numbers of animals used by reducing the variation within and between test groups. It has also improved the overall health of laboratory animals, thus improving their welfare, and has reduced human health risks due to zoonotic diseases. Microbiological standardization is based upon routine testing of the animals at regular intervals (health monitoring).
What is accreditation! Accreditation means that an impartial outside agency has reviewed the operation of a laboratory and found it to be in accordance to the specifications set forth by the laboratory itself. Most laboratories choose to be accredited according to the European Norm (EN) 45001 or the International Standards Organization (ISOl Guide 25 (both documents are virtually identical). Accreditation is on a voluntary basis. It states that the laboratory is sufficiently competent to perform the diagnostic tests it is offering. In the case of laboratory animal diagnostic special emphasis is placed on competency of the staff, validation of in-house test methods, the establishing of a European Reference Centre and the participation in inter-laboratory testing (ring-testing) . Accreditation increases the trustworthiness of a laboratory.
How does it work! Laboratories are audited and accredited by national accreditation bodies, which are members of the European Cooperation for Accreditation of Laboratories (EAL).EAL guarantees that the same standards are used in all member countries. The laboratory has to provide proof that a quality assessment system is in place. This usually consists of a framework of documents, which describe the essential operations of the laboratories. The norms are frequently very ambiguous and the laboratory itself will have to decide how extensive this documentation needs to be. All incidences where errors, which could affect the result of the test, could occur must be identified. The extent of this quality assessment documentation depends on the complexity of the laboratory. Once the laboratory can document that the testing is done according to the specifications, the accreditation body holds the audit and if everything is in order the accreditation is granted. Otherwise a list of items that need to be corrected will be issued to the laboratory. Accreditation is usually for a period of three years, after which the accreditation body will audit the laboratory again. 51:20 FELA5A Working Group on Accreditation of Diagnostic Laboratories laboratories have evolved offering monitoring for pathogens specific to rodents and rabbits. Most tests employed are in-house assays since commercial tests are often not available in this field. Accreditation is a way for the laboratory to show to its clients that it is operating under internationally acceptable standards.
Who needs accreditationf
The Laboratory Accreditation for the laboratory is a seal of approval and can be a marketing tool. It also offers the chance to review the operation, streamline it and improve not only quality but also efficiency of the testing. Interaction with other laboratories during inter-laboratory comparisons can help identify problems and keep the laboratory abreast with new developments.
The Animal Facility Manager Accreditation offers an impartial opinion about the performance of a laboratory, which laymen could otherwise not get. It helps a facility manager to decide which laboratory offers the best service.
The Researcher Knowing that the health monitoring of the experimental animals is conducted in an accredited laboratory increases the confidence in the results of the research conducted with these animals.
How much does it cosU
Cost varies greatly depending on the complexity of the laboratory. When setting up a quality assessment scheme care must be taken only to include essential components. A one-person operation requires much less documentation than a larger laboratory. Cost also depends on how well the laboratory has been organized previously. If all the testing protocols are available and up to date, very little additional documentation is needed. In a laboratory where everything is done without written protocols the efforts to reach accreditation are much greater.
Laboratory Animals (1999) 33 (Suppl. 1) What is FELASA's role in thisf In the past, reproducibility of test results from different laboratories using different test methods has not always been possible (Baneux & LeNet 1997) . The laboratories in the field of laboratory animal diagnostics have addressed these issues by organizing ring-testing on a voluntary basis. FELASA has welcomed such efforts and has decided to promote harmonization of laboratory animal diagnostic by recommending that the laboratories operating in this field seek accreditation. Thus FELASA strongly believes that the overall quality of health monitoring and animal experimentation can be further improved.
Why this guideline and who should read iU
As mentioned before the norms are in many ways very ambiguous since they address a wide variety of testing laboratories. Laboratories that engage in laboratory animal diagnostics, however, have very specific needs. To facilitate the accreditation of these laboratories, FELASA has prepared the following guidelines, which are specifically tailored to the needs of laboratories in this field. It is intended to be the main document that will guide a laboratory through the accreditation process. It should also offer assistance to the auditors and experts engaged by the accreditation bodies when auditing a laboratory performing laboratory animal testing. It should provide interpretation of the norms, which are considered appropriate in the field. This introduction is not part of the guidelines.
FELASA Working Group on Accreditation of Diagnostic Laboratories
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Preamble
The following document was written by the Federation of European Laboratory Animal Science Associations IFELASA)in consultation with the European Cooperation for Accreditation of Laboratories (EAL)to provide guidance on the interpretation of the European Norm 45001 for laboratories engaged in laboratory animal diagnostics. This is only a transitory document which in time will be replaced by a set of documents issued by the EAL,which will cover all issues dealt with in this document. Until such time, the document is supported by the EAL who will use it in their evaluation of laboratories in this specific field. Laboratories wishing to use this document for their own accreditation are advised to check back with their national accreditation body or with FELASAto see if this document is still III use.
To form a stand-alone document this guidance paper contains passages adopted from the joint guidance document of EAL and EURACHEM 'Accreditation for laboratories performing microbiological testing' IEAL-GI81·
1 Introduction and scope of document 1.3 Laboratory animal diagnostic includes the bacteriological, mycological, parasitological, virological and pathological examination of laboratory animals or of samples collected from laboratory animals or of samples collected from the environment of laboratory animals for the purpose of assessing the health status of an individual animal or an animal colony (routine health monitoring). The term laboratory animal may include any animal used in animal experimentation but emphasis is placed on rodents and lagomorphs. Laboratories examining mainly samples from farm or companion animals should seek accreditation in their respective field.
1.4 This document is based on the document 'Accreditation for laboratories performing microbiological testing' issued by EAL and EURACHEM IEAL-GI8) referred to as EAL-GI8 hereafter.
1.5 This document is concerned with the quality of test results. However, it is here noted that laboratory practice should conform to national and international regulation concerning safety, human and animal health and animal welfare.
2 Scope of accreditation (EN 45003 . paragraph 6.6) 2.1 The scope of accreditation of a laboratory is the formal statement of the range of activities for which the laboratory has been accredited. The scope is recorded on an accreditation schedule, which is issued together with the accreditation certificate. In laboratory animal diagnostics the laboratory's scope has to be defined on three levels:
(1) The field of testing: one or more of the four basic categories in laboratory animal diagnostics (pathology, bacteri. ology, parasitology and virology).
(2) The range of animal species from which the tested samples originate from. The area for washing (after decontamination) may be shared with other parts of the laboratory providing that the necessary precautions are taken to prevent transfer of traces of substances which could adversely interfere with testing. The need for physical separation should be judged on the basis of the activities specific to the laboratory (e.g. number and type of tests carried out).
Environment and monitoring
4.2.1 Laboratories must be aware of the potential for contamination of areas both inside and outside the laboratory, and should demonstrate that they have taken appropriate measures to avoid any such occurrence. For example, the laboratory may need to construct physical barriers to isolate the test premises.
4.2.2
The environment within which the analyses are carried out shall be such that results are not invalidated. Depending on the type of testing activities carried out, the laboratory shall define and document the particular arrangements in place for minimizing the risks of contamination.
4.2.3
Space should be sufficient to allow work areas to be kept clean and tidy. The space required should be commensurate with the volume of analyses handled and the overall internal organization of the laboratory. This list is not exhaustive, and not all examples will apply in every situation. Ceilings, ideally, should have a smooth surface with flush lighting. When this is not possible las with suspended ceilings and hanging lights), the laboratory should have documented evidence that they control any resulting risks to hygiene and have effective means of overcoming them, e.g. a surfacecleaning and inspection programme.
4.4.5
The computer equipment ventilation system should be arranged to prevent contamination, i.e. the airflow should not be directed onto the workbenches. 4.4.6 In cases where work under sterile conditions is limited or takes place only occasionally, it may be sufficient to use a clean bench provided that stringent aseptic techniques are used. (EN 45001, paragraph 5.3.3 ; ISO Guide 25, paragraphs 7 and 9) 5.1 As part of its quality system, a laboratory is required to operate a documented programme for the maintenance, calibration and performance verification of its equipment. The basic principles are described in the document 'Calibration and Maintenance of Measuring and Test Equipment in Testing Laboratories (EAL-GI91'issued by the EAL.
Equipment
Maintenance
[Guidance on maintenance of equipment can be found in ISO 7218) 5.2.1 Maintenance of essential equipment shall be carried out at specified intervals as determined by factors such as the rate of use and the manufacturer's recommendations. Detailed records shall be kept.
5.2.2
Attention should be paid to the avoidance of cross-contamination arising from equipment, e.g.:
• disposable equipment should be clean and sterile; • re-used glassware should be properly cleaned;
• ideally, laboratories should have more than one autoclave. However, one autoclave is acceptable provided that adequate precautions are taken to separate decontamination and sterilization loads, and a documented cleaning programme is in place to address both the internal and external environment of the autoclave. Where it is not possible to use devices such as thermocouples, maximum thermometers that have been calibrated within the required temperature range may be used to monitor the autoclave chamber temperatures. A comparison between temperatures indicated externally and the maximum reached inside the autoclave may be made. Records of such checks and details of any corrective action taken shall be recorded.
Uniformity of temperature
The stability of temperature, uniformity of temperature distribution and time required to achieve equilibrium conditions in incubators, water baths, ovens and temperature-controlled rooms shall be established initially and documented, in particular with respect to typical uses (e.g.position, space between, and height of, stacks of Petri dishes). The constancy of the characteristics recorded during initial verification of the equipment shall be checked and recorded after each significant repair or modification. Laboratories shall monitor and retain temperature records of equipment used for testing. cycle, acceptance/rejection criteria set and records maintained. Monitoring shall be achieved by one of the following:
(i) using a thermocouple and recorder to produce a chart or printout; (ii) using a maximum thermometer; (iii! direct observation and recording of maximum temperature achieved.
In addition to directly monitoring the temperature of an autoclave, the effectiveness of its operation during each cycle may be checked by the use of chemical or biological indicators for sterilization/ decontamination purposes. Autoclave tape should be used to indicate that a load has been processed, but not as an indicator to demonstrate completion of an acceptable sterilization cycle.
Weights
Weights shall be calibrated and balances verified at regular intervals by a documented procedure (according to their intended usel. All weights shall be calibrated and traceable to national or international standards. 
Conductivity meters, pH meters
Conductivity meters, oxygen meters, pH meters and other similar instruments shall be verified regularly or before each use. The buffers used to calibrate the instrument shall be stored in appropriate conditions and shall be marked with an expiration date.
Hygrometers
Where humidity is important to the outcome of the test, hygrometers shall be calibrated and the calibration shall be traceable to national or international standards.
Timers
Timers, including the autoclave timer, shall be verified using a calibrated timer or national time signal. 5.3.11 Photometers (ELISAreaders as well as single cuvette photometers) and refractometers Photometers should be checked regularly for the proper function of automatic procedures, lamp function, light direction etc. by either an in-built self-check or by a manual procedure. The accuracy of the estimation of the optical density or refraction should be monitored regularly against a reference standard in order to document that the deviation from the standard value is within the accepted variation range of the instrument. For instruments having an automatic calibration of results each type of test must be regularly validated against a standard or a sample tested by another method or another laboratory.
Thermocycler (PCR)
Temperature and timing in thermocyclers should be checked regularly by internal selfcheck or by using external control devices.
6 Reagents and culture media (ISO Guide 25, paragraph 8.1)
6.1 The laboratory should ensure that the quality of the reagents used is appropriate for the tests concerned. The grade of any reagents used (including water) should be as stated in the method together with guidance on any particular precautions which should be observed in its preparation or use. Preferably, reagents (including ready-to-use media, Petri dishes, slides, microtitre-plates, conjugated antibodies, enzymes and substrates) should be obtained from manufacturers who have a quality certification system certified to ISO 9000. Laboratories should ensure that certification covers all relevant activities including supply/delivery, where this has a bearing on the performance of the goods. Laboratories should initially verify the suitability of the product by using • For (tissue) culture and microscopy methods positive and negative control organisms which are traceable to recognized national culture collections or an organization recognized by the accreditation body. • For immunoassays positive and negative control sera which are derived from international reference material or which previously have been tested by at least two different methods at the laboratory or at two different laboratories. • For molecular biology positive and negative control samples containing either:
• specific nucleic acid which are derived from international reference material; • specific nucleic acid which previously have been tested by at least two different methods at the laboratory or at two different laboratories; • control organisms which are traceable to recognized microbiological/national culture collections or an organization recognized by the accreditation body.
6.2 Each batch received should include an assurance that it is supplied in accordance with the quality specification. In the event of any changes, the manufacturer should supply a revised specification. Distilled water, deionized water or reverse osmosis produced water, free from bactericidal and inhibitory substances, should be used in the preparation of media, solutions and buffers. Guidance on the preparation and sterilization of media, and recommended storage times can be found in ISO 7218. 6.4.5 All laboratory prepared batches of media should be checked to ensure they support the growth of specific microbial cultures. In addition, selective media should be checked to ensure they suppress the growth of non-target organisms. In preference to using the commonly used streak method, it is better to use a quantitative procedure, where a known (often low) number of relevant organisms are inoculated onto the medium under test and the recovery evaluated. This can be used to establish a recovery level below which a batch will not be accepted.
6.5 Non-culture methods 6.5.1 Antigens may be purchased from external manufacturers according to article 6.1. They may as well be propagated and prepared in the laboratory. All laboratory prepared batches of reagents (e.g. antisera, antigen, culture, primers, probes) (if relevant) should be checked for absence of cross-contamination by other reagents prepared in the laboratory. Information like batch number (or equivalent), date of production, the protocol of the actual production procedure as well as all information of the original quality control test should be documented. 6.5.2 Commercially obtained antigens, antibodies and other reagents must not be used after the expiration date given by the manufacturer. Date of receipt, expiration date and opening date should be recorded. The stock should be rotated so that older antigens, antibodies and reagents are used first. Antigens, antibodies and reagents produced in the laboratory, as well as commercially obtained antigens, antibodies and reagents with no expiration date must be given an expiration date by the laboratory based upon the laboratory's own judgement. 6.5.3 Where laboratories are making use of pre-prepared antigens, antibodies and other reagents, they should obtain a copy of the ISO 9000 registration certificate from the suppliers of the goods. It is recommended that further checks should be made on products on a random basis to ensure continued compliance with the required specification. Purity tests must be made on each batch of in-house antigens or commercially obtained antigens not being tested by the manufacturer. These checks may be encompassed by a laboratory's in-house regular QC programme. The manufacturer should initially supply a 'quality specification' which will include at least the following:
(al shelf life of the product; (b) storage -conditions; (cl'purity checks including the sera used; (d) efficacy checks using sera of known titres previously being tested by two different methods or the same method at two different laboratories; (el date of issue of specification.
Each batch received should include an assurance that it is supplied in accordance with the quality specification. In the event of any changes, the manufacturer should supply a revised specification. 7.1 Laboratories may use sectorial, official, national, and international standard methods and in-house methods. The laboratory should not feel constrained to use a standard method if it has an in-house method which has equivalent or superior performance, more modern technology and a degree of validation adequate for the purpose. The laboratory should satisfy itself that each particular method is adequate for its intended purpose. 7.2 The trueness, repeatability/reproducibility, specificity, sensitivity, limit of determination, matrix effects and ease of use must be taken into account before selecting a particular test method. Laboratories should select methods which are suitable for their purposes (see Section 9). 7.3 Methods used by a laboratory shall be fully documented. A recommendation for these procedures is given in ISO 78/2, Layouts for Standards: Part 2.
8 Validation methods and verification of performance 8.1 Each laboratory will have particular requirements for the performance characteristics of a particular method in order to demonstrate suitability for the intended purpose. However, the essential feature of any method is that it should give the 'correct' answer with respect to specified limits of detection, selectivity, repeatability and reproducibili ty.
8.2 For official methods, or methods from recognized national or international standard organizations, a full validation may not be necessary but, before using such a method for the first time, the laboratory should introduce it by a documented training programme. Basic parameters like variation, selectivity, sensitivity and specificity can generally be found in scientific publications, books and manuals for microbiological media.
8.3
Commercialized test systems (kitsl may not require further validation if validation data from alternate sources, e.g. based on collaborative testing, is available. Laboratories should seek from manufacturers validation data and evidence of operation to a recognized quality assurance system. Where full validation data are not available, the laboratory is responsible for completing the validation of the method before using it routinely.
8.4 For all other methods, validation must be performed to assure the reliability of the obtained results and, if possible, to establish the results dispersion. 8.5 All validation data must be recorded and stored for at least as long as the method is in force and as long as necessary to ensure adequate traceability of raw data and results. 8.6 Participation in, or organization of, collaborative trials, proficiency testing, or interlaboratory comparisons, whether formal or informal, is also a means of checking the validity of methods but it is recognized that Laboratory Animals (1999) 33 (Suppl. 1) this is not always feasible. The analysis of samples using both the proposed new method and existing methods for the same determination would assist in establishing the efficacy of a method. 8.7 If a modified version of a method is required to meet the same specification as the original method, then comparisons should be carried out using replicates to ensure that this is the case. A statistically acceptable number of samples should be analysed by each procedure to ascertain whether any difference in the results is statistically significant.
Methods detecting the presence of an organism
8.8.1 Methods that detect the presence of (parts) of the microorganism can be compared directly with each other. Qualitative microbiological test methods (in which the response is expressed in terms of presence/absence) should be validated by estimating, if appropriate, the specificity, relative trueness, positive deviation, negative deviation, limit of detection, matrix effect, repeatability and reproducibility (see EAL-G18 Appendix A for definitions). 8.8.2 For quantitative microbiological test methods, the specificity, sensitivity, relative trueness, positive deviation, negative deviation; repeatability, reproducibility and the limit of determination within a defined variability should be considered and, if necessary, quantitatively determined in assays. The differences due to the matrices must be taken into account when testing different types of samples. The results should be evaluated with appropriate statistical methods.
8.8.3
The validation of microbiological test methods should be performed under the same conditions as those of a real assay. This can be achieved by using a combination of naturally contaminated products and spiked products.
8.9 Serology methods 8.9.1 Serology methods aimed at giving a qualitative response, i.e. positive or negative, Laboratory Animals (1999) 33 (Suppl. 1) should be validated by estimating their relative specificity and sensitivity in comparison with an analogue method using individual samples for comparison. The analogue method could be another in-house test, a commercial kit or a method employed at an accredited laboratory. If available, a method detecting the presence of an organism should be used as reference method for the validation of serology methods. 8.9.2 It is often difficult to assign a true or absolute value to serological systems with no 'gold standard' available with a 100% sensitivity and specificity. In this setting the concepts of sensitivity and specificity of a new test are ill-defined and should not be used. If the true infection status of the animal is not known, results of the new test and reference test should be displayed in tabular or graphic form, and areas of disagreement should, if possible, be investigated by other diagnostic tests (e.g. immunoblot, peR). 8.9.3 A statistically relevant number of samples, if possible, from colonies with a well defined microbiological status (positive and negative, shown by an alternative method or because the infection has been introduced experimentally) should be analysed. If due to the improvement of the health status of laboratory animals no samples from naturally infected animals are available, validation is limited to the use of samples from experimentally infected animals. The reproducibility of these methods should be estimated.
Note: Methods that detect the presence of (parts) of the microorganism and serological methods will often not agree fully when data on individual animals are compared. Both types of method should however yield the same conclusion as to whether an animal colony is infected or not upon the examination of a statistically valid number of samples 8.10 Even when validation is complete, the user will still need to verify that the documented performance can be met, e.g. by the use of spiked samples prepared from reference cultures or reference material. Participation in inter-laboratory comparisons is mandatory. This may either be established as a ring test organized by several laboratories, or by the individual laboratory by sending samples tested by the laboratory for other laboratories for comparison.
Note:
• (Diagnostic) sensitivity is the probability that the test will be positive when the animal truly is (or was) infected. • (Diagnostic) specificity is the probability that the test will be negative when, in fact, the animal is (or was) not infected.
9 Quality assuranceof results/quality control (EN 45001, paragraph 5.4.2 (e) and (f); ISO Guide 25, paragraph 5.6) 9.1 Quality assurance is the programme of activities carried out by a laboratory intending to improve laboratory performance generally. The activities include encouragement of the constant use of internal quality control, support of external assessment schemes, and all measures taken to increase both within and between laboratory reproducibility by means of training courses, conferences, and collaborative studies of laboratory methods.
9.2 Internal quality control 9.2.1 Internal quality control consists of the procedures undertaken by a laboratory for the continual evaluation of the work of the laboratory. The main objective is to ensure that day-to-day consistency of measurement is in agreement with some agreed value, such as by comparison with the agreed characteristics of molecules, cells, organisms or with the assigned values of control materials where these exist. When consistency is not achieved, control must be exercised over the release of results. Reference material should be regularly tested against these 'international standards'.
Note: International reference material consists of cut-off control sera for immunological assays and low-level positive samples containing specific nucleic acid for molecular biology methods. Monospecific control sera may be generated by the following procedure: pathogen-free animals are experimentally infected with an organism, where possible by natural route (nasal, oral or oronasall to minimize extraneous antibodies. Animals are kept under barrier to prevent external contamination. Positive sera are collected and diluted with negative sera of the same species. Serial dilutions, made in negative serum, are tested and a consensus cut-off value is determined by inter-laboratory comparison. One designated laboratory stores the appropriately diluted cut-off serum and makes it available to other laboratories as reference material. These international reference materials are reexamined at intervals by inter-laboratory comparison to adjust their values to the present situation. Different laboratories may store different international refer-Laboratory Animals (1999) 33 (Suppl. 1) ence materials. FELASAkeeps a record where the retainers of all international reference materials are listed. 9.4.3 Reference materials and substances and certified reference materials shall be stored and handled under conditions that do not alter their integrity, in accordance with a documented procedure and the relevant test method. 9.5 External quality assessment (proficiency testing) 9.5.1 Externally organized proficiency testing schemes provide an independent means by which a laboratory may objectively assess and demonstrate the reliability of results produced by its analytical methods. Participation provides a means for a laboratory to measure its own performance against that of other laboratories. It is important to monitor proficiency testing results as a means of checking quality assurance and to take appropriate action as necessary. 9.5.2 In the field of laboratory animal diagnostics the majority of methods used are inhouse methods. Inter-laboratory comparisons are therefore a crucial scheme in establishing and maintaining test methods in this field. Laboratories should participate in proficiency testing as an important part of their quality assurance protocols. Laboratories should regularly participate in programmes which are relevant to their scope of accreditation. 9.5.3 Requirements of proficiency testing is described in ISO Guide 43. Acceptable interlaboratory comparison programmes consist of at least three independent laboratories from at least two different countries. Minimal frequency should be four times annually with at least two samples each time. Test samples may include one or more of the following:
• 11.9 The packaging and labels from samples may be highly contaminated and should be handled and stored with care so as to avoid any spread of contamination.
11.10 The preparation of the laboratory sample and the test portion should follow the national or international standards specific to the tested products (if available) and the general guidance given in ISO 6887 and ISO 7218.
11.11 Sample preparation may simply involve stirring a sample and measuring an aliquot (e.g. liquids) or may require a multistage reconstitution and sub-culturing (e.g. dried products). In either case the laboratory should be able to demonstrate that:
(a) the test portion is as representative of the product as possible (when relevant) and suitable for analysis; (b) contamination of the test portion and the environment has been avoided (see Section 4).
11
.12 A procedure for the retention and disposal of samples shall be written. Laboratory sample portions that are known to be highly contaminated shall be decontaminated prior to being discarded. They should be stored until the test results are obtained, or longer if necessary. of sample analysis, however it is a matter of good laboratory management and should conform to national/international environmental or health and safety regulations (see also ISO7218).
Uncertainty of measurement
13.1 The international definition for uncertainty of measurement is given in ISO international vocabulary of basic and general terms in metrology: 1993. .
13.2 It is recognized that the current state of knowledge regarding uncertainty of measurement across the full range of microbiological disciplines is variable. For this reason, laboratories may not currently have access to appropriate guidance on estimating uncertainty of measurement in their particular discipline. This situation is currently being addressed within the laboratory community and it is expected that more clearly defined guidance in the field of microbiology will be available in future. However, repeatability and reproducibility data are components of uncertainty of measurement and should be determined as a first step towards producing estimates of this parameter.
13.3 Uncertainty of measurement may be provided as follows:
• Pathology:
• The personal conviction of the person reading the slide as to the correctness of the diagnosis.
• Serology:
• The specificity and sensitivity of the assay as determined by the validation procedure.
• Bacteriological culture:
• Probability of identification as provided by commercial test systems such as panels of biochemical tests for identification.
• Profiling of chemotaxonomic characteristics (e.g. gas chromatographic cell wall lipid profiling by an automated microbial identification system, giving a similarity value between 0.0-0.999) 13.4 The basic principles are described in a soon-to-be-released document issued by EAL. 14.1 Where well established software is used for the purpose of communication or analytical work, no particular validation is necessary.
14.2 Where in-house software is used, complete documentation for validation purposes must be provided. Furthermore, it must be shown that loss or corruption of data does not occur.
14.3
Where software is updated, a record of the revisions must be retained.
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Appendix A Guidance on calibration and calibration checks
This information is provided for guidance purposes and the frequency will be based on the need, type and previous performance of the equipment. 
